All posts by imreal

The Journey Venture Studio Is Accepting Applications For Inaugural Cohort Of Its Founder-In-Residence Program For Diverse, Aspiring Healthcare Entrepreneurs


News Image

The new program gives minority and women leaders the financial support, skills, and training necessary to succeed in the venture world while accounting for cultural sensitivities and challenges unique to underrepresented groups.

The Journey Venture Studio announced the launch of its first Founder-In-Residence cohort, focused on matching diverse aspiring entrepreneurs with healthcare startup concepts. The new program gives minority and women leaders the financial support, skills, and training necessary to succeed in the venture world while accounting for cultural sensitivities and challenges unique to underrepresented groups.

The Journey is on the hunt to find top talent from across the U.S., actively recruiting through college campus visits including Arizona State University, Harvard Business School, Stanford University, The Wharton School of the University of Pennsylvania, Kellogg School of Management at Northwestern University, University of Chicago Booth School of Business and The Stanford Graduate School of Business, although underrepresented entrepreneurs can apply from anywhere in the U.S.

For its inaugural cohort, The Journey seeks aspiring entrepreneurs excited to explore business opportunities in one of the following healthcare focus areas:

Mental Health

Sports Medicine

Women’s Health

Aging & Elder Care

Chronic Disease Management

Packaging & Supply Chain

Its first cohort is set to start Sept. 1 and applications are now open through May 5. To be eligible to participate, entrepreneurs must be prepared to move to Phoenix for the six-month program; $100,000 of direct and in-kind financial support is provided to relocate to Phoenix and prototype and test venture concepts.

Aspiring entrepreneurs will go through a rigorous interview process. Once a founder is accepted, they will be set off on an intensive growth program designed to jump-start a new venture. During their time in the program, founders can leverage the team’s network and other community resources. The Journey will provide hands-on support, investment, mentorship, and programming, allowing founders to develop, prototype, and scale their startups. At the end of the six-month residence program, founders will pitch in front of The Journey Board, sponsors, and partners to determine which concepts will receive additional funding to go to market.

“Entrepreneurship is a critical pathway for closing the wealth gap and central to opportunity in our country, yet many of our best and brightest aren’t pursuing that path because of a host of systemic barriers; lack of access to capital, mentorship, and training being just a few of them” said Mark Moeremans, Managing Director of The Journey and former Senior Vice President of entrepreneurship and venture development for the Arizona Commerce Authority. “That is what The Journey Venture Studio is here to do. We are here to remove the obstacles that have historically prevented the success of diverse entrepreneurs.”

The Journey is the brainchild of Moeremans and healthcare entrepreneur and investor, Justin Bayless, who recently exited Bayless Integrated Healthcare, a family business he scaled and grew from six employees to 600 employees and to nine locations prior to selling the majority stake to a Fortune 25 healthcare company in 2020.

“Unlike an accelerator or incubator, a venture studio doesn’t fund existing startups. It’s a company that creates multiple startups in house, then partners with entrepreneurs to grow them,” said Bayless who serves as President of The Journey Venture Studio. “Our goal with the Founder-in-Residence program is to identify, inspire, educate, and empower diverse entrepreneurs in our tailored six-month venture program to increase their odds of success and give them a real chance to swing for the fences.”

The Founder-In-Residence program also provides opportunities for investors and philanthropists to get involved. For investors, the studio offers a new source of high-quality deal flow in the healthcare space. As a 501c3 not-for-profit, the studio offers a unique opportunity for philanthropists and donors to support a mission-driven organization at the cross section of racial justice, health equity, and leadership development and education while simultaneously offering early visibility into portfolio companies for potential investment. For more information, please visit https://thejourneyventures.com/.

The Journey Venture Studio

The Journey, a Phoenix-based 501c3 not-for-profit entity, is a venture studio creating and launching healthcare companies to be led by underrepresented founders. With a mission to launch healthcare companies aimed at improving health outcomes while creating opportunities for historically underrepresented entrepreneurs from around the country through a tailored venture fellowship, The Journey will activate a new generation of diverse founders; leveling the playing field and bringing world-changing healthcare solutions and technology to life.

Share article on social media or email:

Biggest Risk Factors for Emerging and Mid-market Biopharma Companies, Costly Clinical Trial Delays


News Image

The risks are highest at the beginning. Persistent pain points plague every clinical trial, such as the inevitable protocol amendments that need to be planned for rather than reacting to them as a surprise—which can exponentially delay the process and increase the costs

Aspirin, the original wonder drug, and its use as an analgesic and fever reducer can be traced back to 500 BC. Over the decades of the 20th and 21st centuries, the U.S. Food and Drug Administration (FDA) has approved the use of aspirin to manage and treat several health conditions, including in the prevention of strokes, heart attacks, and colorectal cancer.(1) But the next miracle drug can’t come quickly enough for patients suffering from chronic illnesses, cancers, rare diseases, and other debilitating health disorders. In 2022, the FDA approved 37 novel drugs, the lowest number to pass the regulatory rigors of the FDA’s Center for Drug Evaluation and Research (CDER) since 2016.(2) According to Deloitte, the cost of the research and development (R&D) of one new drug rose 15% ($298 million) in 2022, to approximately $2.3 billion per therapy among the top 20 global biopharmaceutical companies.(3)

Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics and Jeeva™ eClinical Cloud, understands the persistent challenges and pitfalls of bringing new drugs to market. “For proper planning and risk mitigation,” Rajasimha says, “the clinical trial operational strategy needs to begin six to nine months BEFORE the trial begins. It needs to be a front-loaded effort to minimize the biggest risk factors first.”

Clinical trials comprise 6 to 7 years of the average 10-year span for the successful research and development of a drug from the initial discovery phase to its release into the healthcare marketplace. Unfortunately, less than 12% of candidate drugs make it that far.(4)

While patient enrollment has been historically difficult for Big Pharma, small and emerging biopharmaceutical sponsors of clinical trials are particularly challenged with significantly lower capital to work with when coordinating recruitment efforts.

In order for emerging pharma and biotech companies to achieve more with less money and resources, they need to begin by recognizing and addressing the biggest risk factors first. Studies indicate that 85% of all clinical trials are delayed due to difficulties with patient recruitment.(5) With an average dropout rate of 30%, each day of delay can cost approximately $600,000 to a staggering $8 million in indirect cost of the lost revenues of the drug/biologic/device.(6)

Some common barriers to patient recruitment and retention are:

  • a lack of awareness and disjointed communications;
  • too narrow inclusion and exclusion criteria; and
  • logistical burdens for participants, such as the distance and frequency of travel to investigator-site.(7)

Clinical trial decentralization, when implemented right, has been instrumental in accelerating the recruitment process, increasing enrollment diversity, and encouraging continued participation and patient engagement with reduced burdens.(8)

Dr. Rajasimha cautions, “The risks are highest at the beginning. Persistent pain points plague every clinical trial, such as the inevitable protocol amendments that need to be planned for rather than reacting to them as a surprise—which can exponentially delay the process and increase the costs.”

On average, a clinical trial goes through about 2 or 3 protocol amendments. Such amendments can suspend patient enrollment eligibility, and sponsors and contract research organizations (CROs) don’t often have a plan or budget for them. The Tufts Center for the Study of Drug Development estimates that protocol amendments implementation costs pharmaceutical and biotechnology companies $7 billion to $8 billion annually across phase II and III clinical trials.(9)

Frantz Viral Therapeutics (FVT), a joint venture of Georgetown University Medical Center and Frantz Medical Group, recently selected the Jeeva eClinical platform to effectively execute a multi-site phase 2 clinical trial focused on the treatment of anal squamous intraepithelial lesions (anal HSIL—abnormal cells in the lining of the anus).

“During the different phases of a clinical trial, as we evolve in our knowledge of the product, the disease, and patient population, amendments need to be implemented on a regular basis. [Jeeva] has been able to implement requested amendments to its compliant system within 24 hours.” says Mihaela Plesa, BA, CCRP, Director of Clinical Operations at FVT.

Dr. Rajasimha explains, “Clinical Trial operations need to be focused on the right aspects at the right time, especially up front.”

Jeeva eClinical Cloud helps biopharmaceutical and medical device clinical trial sponsors to achieve more with less money and fewer resources.

To continue the discussion regarding these considerations with clinical research professionals, Rajasimha will be at the ACRP conference at Sheraton, Dallas, TX April 29 – May 1, 2023 and at Philadelphia for the outsourcing clinical trials east conference on May 23, 24.

About Jeeva Informatics

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

References

1. Ugurlucan, M., M. Caglar, I., N. Turhan Caglar, F., Ziyade, S., Karatepe, O., Yildiz, Y., Zencirci, E., Gungor Ugurlucan, F., H. Arslan, A., Korkmaz, S., Filizcan, U; Cicek, S. (1970, January 1). Aspirin: From a historical perspective. Latest TOC RSS. Retrieved April 15, 2023, from ingentaconnect.com/contentone/ben/prc/2012/00000007/00000001/art00009

2. Craven, J. (n.d.). CDER approved 37 novel drugs in 2022, its lowest number since 2016. Regulatory Affairs Professionals Society (RAPS). Retrieved April 15, 2023, from raps.org/news-and-articles/news-articles/2023/1/cder-approves-37-novel-drugs-in-2022-its-lowest-nu

3. Philippidis, A. (2023, February 28). The unbearable cost of drug development: Deloitte Report shows 15% jump in R&D to $2.3 billion. GEN. Retrieved April 15, 2023, from genengnews.com/gen-edge/the-unbearable-cost-of-drug-development-deloitte-report-shows-15-jump-in-rd-to-2-3-billion/

4. Pharmaceutical research and Manufacturers of America. (n.d.). Retrieved April 15, 2023, from phrma-docs.phrma.org/sites/default/files/pdf/rd_brochure_022307.pdf

5. Stevenson, K. (2022, January 14). 85% of clinical drug trials face delays. what’s the true cost? MarketScale. Retrieved April 15, 2023, from marketscale.com/industries/healthcare/85-of-clinical-drug-trials-face-delays-whats-the-true-cost/

6. Mdgroup. (2023, February 16). The true cost of patient dropouts in clinical trials. mdgroup. Retrieved April 15, 2023, from mdgroup.com/blog/the-true-cost-of-patient-drop-outs-in-clinical-trials/#:~:text=Approximately%2030%25%20of%20patients%20drop,to%20non%2Dcompliance%20is%20%2419%2C533

7. PMGroup Worldwide Limited. (2020, November 6). What are the biggest barriers in patient recruitment? PMLive. Retrieved April 15, 2023, from pmlive.com/pmhub/clinical_research/couch_integrated_marketing/white_papers_and_resources/what_are_the_biggest_barriers_in_patient_recruitment

8. Mdgroup. (2023, February 16). Why decentralisation is the future of clinical trials. mdgroup. Retrieved April 15, 2023, from mdgroup.com/blog/why-decentralisation-is-the-future-of-clinical-trials/

9. Tuesday, M. 1. (2022, March 1). Doubling down on protocol amendments and Deviations. Pharmaceutical Outsourcing. Retrieved April 15, 2023, from pharmoutsourcing.com/Featured-Articles/584137-Doubling-Down-on-Protocol-Amendments-and-Deviations/

Griswold Celebrates the Dedication of a Memorial Highway in Honor of Late Founder Dr. Jean Griswold on Thursday, April 27, 2023


Griswold, the leading non-medical home care franchise, is proud to announce the approval of Pennsylvania House Bill 2295, which renames a 5.5-mile portion of State Route 301 in honor of the company’s late founder Dr. Jean Griswold. The dedicated section, which will now be known as the Dr. Jean Griswold Memorial Highway, spans from Township Line and Valley Forge Roads in Norristown, PA to Township Line and Walton Road in Blue Bell, PA — the location of the Griswold corporate headquarters.

“This is something that has been in the works for a while, and it is an amazing way to honor my mother’s legacy alongside the 40th anniversary of the Griswold company,” said Kent Griswold, her son. “When my mother started Griswold, there weren’t many other options for people who needed in-home care. She was a true visionary in the industry, and it is great that the legislature found a way to recognize her life and accomplishments.”

The Dr. Jean Griswold Memorial Highway

The bill was introduced in the Pennsylvania State House of Representatives by Representative Mary Jo Daley (D-148). A ceremony to honor Dr. Jean Griswold with the dedication of a Memorial Highway in her name will be held at 11 a.m. EST on Thursday, April 27. The event will take place outside of VEVA Building 12 at 1777 Sentry Pkwy W, Blue Bell, PA 19422.

“Our family is very much looking forward to the ceremony,” said Kent Griswold. “While we are sad she isn’t still here with us to see the recognition, it is a nice way to remind others of the work she has done.”

Attendees of the event will include Sen. Maria Collett, Rep. Greg Scott, Rep. Daley, the Griswold family, Griswold staff, Mike Slupecki (CEO), and the Griswold executive team.

An Inspiring Journey

Griswold was born while Dr. Jean Griswold was sitting at her dining room table in suburban Philadelphia after an elderly woman in her community passed away, all because she had no support system in order to receive care. Dr. Jean Griswold was deeply saddened by what she felt was an easily preventable tragedy and was driven to act. A true visionary, she established one of the most successful non-medical home care organizations in the country.

When Dr. Jean Griswold established Griswold in 1982, she was already 51 years old and had been living with multiple sclerosis (MS) for twelve years, a condition that had left her wheelchair-bound. MS is a devastating illness that targets the central nervous system, damaging the protective layer around nerve fibers and disrupting communication between the brain and the rest of the body. Some individuals with MS, like Dr. Jean Griswold, may lose their ability to walk, while others may experience extended periods of remission.

An extraordinary woman characterized by her faith and empathy, Dr. Jean Griswold’s journey with MS allowed her to experience a deep level of empathy for those in need of care and support. Her personal experience with the necessity for in-home care for adults and seniors grappling with disabilities, illnesses and injuries gave her a perspective that was significant to Griswold’s success. Like many others in similar situations, Dr. Jean Griswold desired to stay in the place where she felt most at ease — her home.

At that time, Dr. Jean Griswold was a lecturer at a nearby college, giving her access to certified nursing assistants (CNAs) and students enrolled in nursing programs. She utilized this network to assemble her team, mobilizing her resources and leveraging personal connections to provide care for those confined to their homes. It quickly became apparent that her newfound business partners and staff shared a common enthusiasm for giving back to their community and ensuring a high quality of life for those in need.

“A lot of people wouldn’t have believed my mother could achieve what she achieved,” said Kent Griswold. “She didn’t listen to the naysayers and always found a way to make it work. She showed people that they can’t let those hurdles stop them. If you can find ways to overcome them, you can always move forward.”

Dr. Jean Griswold was born in New York City, earning a bachelor’s degree in economics and business from Douglass College and a master’s degree in personnel and guidance from Rutgers University. In 2006, she was awarded an honorary doctorate by Holy Family University.

Between 2003 and 2004, Dr. Jean Griswold served as the Entrepreneur in Residence at the Wharton School of the University of Pennsylvania. Her accomplishments were recognized through various accolades, such as the Spirit of Philadelphia Award, the Working Woman’s 2001 Entrepreneur of the Year distinction and the 2002 MS National Achievement Award presented by the National Multiple Sclerosis Society. Dr. Jean Griswold passed away in 2017 at the age of 86.

Keeping the Griswold Mission Alive Down the Road

Today, Dr. Jean Griswold’s legacy continues to inspire and impact the lives of countless seniors and their families, with a network of more than 170 independent Griswold franchise units operating across the country. Not only does Griswold allow prospective franchisees the opportunity to give back to their local communities, but it also offers the opportunity to join a $136.2 billion industry, as the senior population is rapidly increasing while baby boomers approach retirement.

Dr. Jean Griswold’s passion for supporting caregivers and her belief in the power of education is also honored through Griswold’s non-profit organization The Jean Griswold Foundation, which is set to award $100,000 in scholarships this year to caregivers from across the country with amazing stories of perseverance and fortitude.

Looking forward, Kent Griswold is optimistic about the future of the Griswold brand and the non-medical home care industry at large. As the industry evolves, Griswold will continue to provide compassionate and high-quality care, honoring Dr. Jean Griswold’s legacy and vision for helping seniors live independently and comfortably in their own homes.

“Whether it is caregivers, clients, franchisees or the community, Griswold is all about showing that one person can make a big difference,” said Kent Griswold. “There is always going to be a need for home care, and the senior population is only going to grow. Now, Griswold has an amazing opportunity to help more people in the future. The Dr. Jean Griswold Memorial Highway is a great way to recognize the hard work we have already done and to celebrate the life of the person who made it all possible.”

To learn more about Griswold’s services, visit https://www.griswoldhomecare.com/.

To learn more about franchising with Griswold, visit https://griswoldhomecarefranchise.com/.

ABOUT GRISWOLD

With 170 locations in 31 states, Griswold is one of the country’s top home care companies, providing professional, compassionate caregivers 24/7. Griswold’s “Live Assured” promise gives both clients and their loved ones peace of mind, so they can live without the weight of worry. Griswold helps adults maintain quality of life despite advanced age, onset of illness, or post-surgery recovery through services including companion care, home services, personal care, and respite care. Founded by the late Jean Griswold in 1982, the company has maintained its founder’s profound sense of empathy for older and disabled adults and those living with chronic conditions. In 2023, Griswold was ranked #267 on Entrepreneur’s Franchise 500 and named a 2023 Best of Home Care® Endorsed National Provider. For more information, visit http://www.griswoldhomecare.com or call 215.402.0200.

Vector Solutions Launches Its Guardian Tracking Solution For Fire Service And EMS Agencies


Today, Vector Solutions, the leading provider of impactful technology solutions dedicated to training, preparing, and retaining first responders and other licensed professionals in the world’s most critical industries, announced the launch of its Guardian Tracking solution for Fire Service and EMS agencies. Guardian Tracking is a performance management and early intervention solution that equips first responders with a process for consistent feedback and positive recognition, and helps identify those in need of intervention before an adverse event takes place. The solution has already been widely utilized across the law enforcement and 911 emergency communications and will now be available to the full spectrum of first responders.

Therefore, addressing how the role the mental and physical health of our first responders plays in day-to-day situations is essential for continuing to protect and serve the public. Both physical and mental health remain critical issues for all first responders. Though the physical dangers for first responders are more obvious, the overall dangers and risks do not end in the field of duty. The National Fallen Firefighters Foundation estimates that there are between 100 and 200 firefighter deaths by suicide each year, double the rate of the general population. “According to Jeff Dill, founder of the Firefighter Behavioral Health Alliance, as of April 24, 2023, the organization has validated a total of 1888 suicides, 96% of which occurred between 2000 and present day. In 2023 alone, FBHA has validated 24 firefighter losses and six EMS losses. The FBHA was founded in 2010 and offers education to firefighters, EMS and dispatcher personnel, and their families about behavioral health issues such as depression, post-traumatic stress disorder (PTSD), anxiety, addictions, moral injury, as well as losses to suicide.” Additionally, according to the PTSD 911 documentary, 34% of police officers, up to 24% of 911 dispatchers, and up to 24% of firefighters suffer from PTSD. Addressing the risk to first responder physical health is also of utmost importance as increasing evidence validates the risk of developing cancer over time for those in the fire service.

To help address these challenges, Guardian Tracking’s unique Early Intervention (EI) software identifies trending behaviors and potential issues that may stem from triggering events. The software easily notifies supervisors of EI flags, tracks exposures and sends notifications when thresholds are met allowing them to act quickly. Additionally, 24/7 web-based access makes it easy to provide systematic feedback and peer-to-peer or supervisor-to-personnel recognition in order to build a desirable, productive workplace. Implementing an early intervention system like Guardian Tracking enables public safety agencies to focus on increasing communication, transparency and retention.

Other benefits include, but are not limited to:

  • Better Safety and Wellbeing – When EI flags are added, supervisors who know their team can make the best decisions on how to help (mental health days, rest, counseling, training, etc.).
  • Protect the Health and Well-Being of Personnel – Through exposure tracking, at-risk first responders are flagged in the system for increased screening. In addition, proactive health screenings assure that first responders receive the healthcare they need.
  • Attract and Retain Top Talent – Recognizing positive performance is one of the most powerful tools a manager can use to create a culture that attracts and retains top talent.

“At Vector Solutions, our mission is to serve frontline workers and everyday heroes by delivering intelligent software solutions that empower them to make decisions and take actions that positively impact themselves and their community,” said Jonathan Cherins, CEO at Vector Solutions. “We are thrilled to offer the Guardian Tracking solution to Fire Service and EMS agencies to equip more public safety personnel with tools to support behavioral health programs, exposure tracking and proactive health screenings, and a platform for consistent feedback and recognition for all first responders. Early intervention systems help identify those in need of intervention before an adverse event takes place, making a tremendous difference in the lives of first responders and the communities they serve.”

“Guardian Tracking offered us an opportunity to strengthen our recognition procedures and ensure better consistency in our documentation,” said Tyler Grace, Fire Management Analyst at Buffalo Grove Fire Department. “We have a high overtime volume and young lieutenants bouncing from one station to another who may not have consistent insight to pick up behavior patterns, whether negative or positive.”

Guardian Tracking can be viewed in action this week (April 24-29, 2023) at FDIC International, North America’s leading firefighter conference, in Indianapolis, Indiana. Attendees can find more information at Vector Solutions booth #1912.

For more information, visit https://www.vectorsolutions.com/solutions/guardian-tracking/

ABOUT VECTOR SOLUTIONS for FIRE & EMS

Vector Solutions for Fire & EMS is the industry leader in training and workforce management technology that enables Fire and Rescue Departments to meet their demanding training, compliance, and preparedness objectives. The Vector Solutions public safety suite of products includes software for training management, policy distribution, personnel scheduling, critical incident and exposure tracking, and promoting a positive department culture. Its online course library includes more than 450 hours of fire department training with 250+ hours of CAPCE-approved EMS recertification courses. Trusted by 10,000 public safety agencies and 2 million first responders, Vector’s purpose-built technology streamlines the full lifecycle of personnel management because readiness saves lives. For more information about Vector Solutions for Fire & EMS, visit https://www.vectorsolutions.com/industries/public-safety/.

ABOUT VECTOR SOLUTIONS

Vector Solutions is the leading provider of impactful technology solutions dedicated to driving safer, smarter, better decision-making in the world’s most critical industries. Embedded into daily workflows to drive improvements in compliance, safety, performance, and preparedness, our software includes training management, industry-focused online course libraries, EHS management, workforce scheduling, risk communication, operational readiness, and more. Vector’s unique combination of information and technology – delivered when and where it is needed – is integral to our more than 34 thousand clients looking to achieve better outcomes and safeguard lives. Vector is committed to providing resources to support those who need them most and launched a collection of free courses on critical mental health and safety topics through Vector Cares. For more information, visit http://www.vectorsolutions.com. For access to free Vector Cares courses visit https://www.vectorsolutions.com/about-us/vector-cares/

Share article on social media or email:

How IAQ Helps Prevent the Dangers of EPA-Flagged Air Pollutants


Indoor air pollution is a growing concern that can have serious health consequences, including respiratory problems and even death. IAQ is a first-of-its-kind smart air quality monitor that can measure more than 20 air pollutants, including all of the worst contaminants flagged by the EPA.

Unfortunately, many people aren’t aware of the dangers of low indoor air quality. For example, because we spend so much time indoors, indoor air is actually more likely to create health problems than outdoor air. According to the World Health Organization, indoor air pollution contributes to millions of deaths globally every year.

To raise awareness on the threat of low air quality, IAQ recently released a guide to the 13 primary air pollutants flagged by the EPA, providing in-depth information on their sources and their impact on health, as well as tips and advice on how to reduce the risk from indoor air pollution.

“When I first began looking into air quality I was shocked by how many dangerous indoor air pollutants were in my home’s air,” said IAQ co-founder Josh Odmark. “But most surprising was how difficult it was to get my hands on a device capable of alerting me to these dangers.”

IAQ was designed to address these challenges. It is affordable, easy to use, and can monitor for every dangerous indoor air pollutant. With IAQ, consumers can receive real-time data and alerts through a seamless integration with popular smart home systems, making it easier than ever to take control of indoor air quality.

“As veterans in the big data and machine learning industries, Josh and I believe harnessing air quality data is the key to doing something about it,” said IAQ co-founder Gideon Rubin. “IAQ puts data in the hands of the user and empowers them to take action.”

IAQ is more than just a device—it’s a mission to deliver a sensible approach to measuring and taking control of indoor air quality. The company believes that making the world healthier and cleaner starts in your own home.

To support this mission, IAQ has launched a Kickstarter campaign. Visit the campaign page to learn more, contribute, and help bring this revolutionary air quality monitor to homes everywhere.

Share article on social media or email:

USOSM Recognizes Dr. Richard Kim for 10 Years of Medical Mission Work in Belize


Dr. Kim and his colleagues provided dental services to more than 50 patients during this year’s trip to Ambergris Caye, Belize.

“It’s truly moving to see the difference that we’re making. It’s always a humbling and rewarding trip for all of us, who volunteer.”

U.S. Oral Surgery Management(USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – congratulates its surgeon partner Richard H. Kim, DDS, MD, as he returns from his 10th annual trip to Belize. During his week-long trip, Dr. Kim and his colleagues provided dental services to people in need, in Ambergris Caye, which is the largest of the 200-plus islands located off the coast of Belize.

“USOSM deeply appreciates the passion Dr. Kim has for helping those in need,” said USOSM President and CEO Richard Hall. “We applaud Dr. Kim’s efforts in Belize and are excited to support the great work that he’s doing there.”

Over the years, Dr. Kim and his colleagues have treated more than 500 patients in Belize. During his most recent trip, Dr. Kim and his colleagues treated more than 50 patients, through two dental clinics: the dental clinic at the Holy Cross Anglican School and the San Pedro Polyclinic.

“We help both children and adult patients with a variety of dental needs,” said Dr. Kim. “In the past, pathologies such as squamous cell carcinoma and osteoblastoma have been identified. Frenectomies and simple soft tissue closure of alveolar clefts also have been performed. This year, the majority of what I did, was the surgical removal of non-restorable and/or infected teeth because the people on the island were not seeing dentists in the past two years, due to COVID-19. I also removed some simple, benign lesions — such as fibromas and papillomas.”

“Many of our patients wouldn’t have received treatment otherwise,” continued Dr. Kim. “It’s truly moving to see the difference that we’re making. It’s always a humbling and rewarding trip for all of us, who volunteer.”

Dr. Kim also is an active volunteer in his community and in other communities in Minnesota. He started volunteering in Belize more than 10 years ago, at the request of the chairman of Minnesota State University’s dental hygiene department. He asked Dr. Kim to lead their group of hygiene staff and students – in conjunction with fellow dentist colleagues and oral surgeons – to “go help the people of Belize.”

“When this opportunity arose, I felt compelled from my upbringing, as a son of a pastor, to answer to this calling,” said Dr. Kim. “Helping people who are in need is a responsibility and an honor.”

A board-certified oral and maxillofacial surgeon, Dr. Kim practices a full-scope of oral and maxillofacial procedures at Southeastern Minnesota Oral & Maxillofacial Surgery – an oral and maxillofacial surgery practice with locations in Mankato, Owatonna, and Rochester, Minnesota. His clinical interests include dentoalveolar surgery, dental implants and anesthesia.

Dr. Kim earned his bachelor’s degree in biology from the University of Chicago, his Doctor of Dental Surgery from Northwestern University Dental School, and his Medical Degree from the Mayo Clinic Alix School of Medicine. Dr. Kim also completed a comprehensive, six-year oral and maxillofacial surgery residency program at the Mayo Clinic.

He is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American Association of Oral and Maxillofacial Surgeons. In addition, he is a member of the Minnesota Society of Oral and Maxillofacial Surgeons, the American Dental Association and the Minnesota Dental Association. Dr. Kim is certified in Advanced Cardiovascular Life Support (ACLS) and is a Basic Life Support CPR instructor.

“There are volunteer opportunities available at these two clinics in Belize, throughout the year,” adds Dr. Kim. “It’s a great opportunity to help others and to form lasting relationships with your referring dentists and other colleagues.”

Dental professionals, who are interested in volunteering in Belize, can contact Dr. Mark Johnson, head of the dental clinic at the Holy Cross Anglican School. For more information, visit https://hcefoundation.org/how-to-help/volunteer.html.

Headquartered in Irving, Texas, USOSM has partner practices spanning 24 states. A shared services organization, USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all. For more information, visit https://www.usosm.com/.

Share article on social media or email:

FILD Studio Opens Flagship Location in SoHo, Offering Revolutionary Beauty and Wellness Treatments


FILD Studio proudly announces the opening of its flagship location in the heart of SoHo, New York, at 457 Broome St. Founded by the highly sought-after physician Dr. Randa Jaafar, FILD Studio is a revolutionary beauty and wellness brand committed to empowering individuals to take charge of their aging process.

Dr. Jaafar, with extensive knowledge and experience in the field of pain management and aesthetic medicine, has become a trusted name in the industry. At FILD Studio, she and her team of experts have thoughtfully curated an array of treatments and products to address the most common aging concerns. Their team of experts is dedicated to staying up-to-date with the latest industry developments, ensuring that clients receive the most advanced and successful treatments possible. Their commitment to exceptional service begins with a free consultation on all services, designed to create an individualized treatment plan that addresses each client’s unique needs.

FILD Studio’s studio space is a haven of tranquility and comfort, brought to life through the creative vision of the design duo, Architect Riham Alsarout, and branding specialist Oliver Hallarsan. The fusion of modern beauty and vibrant health is reflected in the carefully chosen decor, featuring deep greens and natural wood that invite guests to relax and rejuvenate in FILD’s specialized treatments. With its serene and welcoming atmosphere, FILD Studio provides the perfect environment to unwind and experience a range of innovative treatments that will leave clients feeling refreshed and revitalized.

FILD Studio offers advanced and effective treatments for skin rejuvenation, body contouring, and anti-aging. Having invested in only the best, the experienced estheticians use state-of-the-art equipment and the latest techniques to provide personalized treatments that deliver the best results for each individual client. Whether clients desire a youthful appearance, improved energy levels, or enhanced well-being, FILD Studio has a variety of treatment options to choose from.

“I’m thrilled to open FILD Studio and bring the latest advancements in MedSpa treatments to the people from around the world who live in and visit SoHo and the surrounding areas,” said Dr. Randa Jaafar. “At FILD Studio, we believe that everyone deserves to feel confident and beautiful in their own skin, and we are committed to helping our clients achieve their aesthetic goals with safe and effective treatments.”

FILD Studio’s innovative approach has garnered attention from top publications in the beauty and lifestyle industry, including Yahoo’s In The Know, NBC Select, Fox News, Well+Good, and more.

Located in the heart of SoHo, FILD Studio is open Monday through Saturday, from 9 am to 7 pm. For more information about FILD Studio, Dr. Randa Jaafar, and the services offered, please visit http://www.fildstudio.com or call (646) 876-5566 to book an appointment.

FILD Studio with Dr. Randa Jaafar

457 BROOME STREET, New York, NY

New York, NY 10013

(646) 876-5566

http://www.fildstudio.com/

Share article on social media or email:

Navigating Regulatory Pressures with Automation & Interconnected Data, Upcoming Webinar Hosted by Xtalks


Life sciences companies can leverage advanced technologies like artificial intelligence (AI) to reduce manual effort and save time by shifting functions like ingestion and tracking of health authority correspondence from mostly manual to automated.

Life sciences companies face mounting internal pressures such as inflation, sourcing and manufacturing uncertainty and ever evolving global regulations. Additionally, internal pressures are calling for teams to operate lean and leverage data to solve problems. Together, these external and internal forces present a new wave of challenges for regulatory affairs and operations professionals, especially when managing a sprawling, global product portfolio.

Fortunately, the rapid pace of technology innovation and emerging global data standards provide industry with a new toolset that can be harnessed to bring drugs to market safely and efficiently while achieving commercial success. Life sciences companies can leverage advanced technologies like artificial intelligence (AI) to reduce manual effort and save time by shifting functions like ingestion and tracking of health authority correspondence from mostly manual to automated. Global data standards like ISO Identification of Medicinal Products (IDMP) and HL7’s Fast Healthcare Interoperability Resources (FHIR) promote quick and efficient exchange of information. Interoperability between systems and regions of the world has great potential to lower the cost of operations and create meaningful connections between functional areas such as regulatory and pharmacovigilance.

Join this webinar as ArisGlobal regulatory leaders highlight the potential of intelligent automation and interconnected regulatory data to inform strategic decisions and other key strategies for proactive management of a global product portfolio. They’ll also share use cases and practical steps that regulatory leaders in life sciences can take to ride the next wave of innovation in technology and global data standards.

Join Laura Jones, Director, Regulatory Product Management, ArisGlobal; Robin Schilling, Associate Director, Regulatory Product Management, ArisGlobal; and Renato Rjavec, Director of Products, Amplexor Life Sciences, for the live webinar on Friday, May 12, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Global Product Management: Navigating Regulatory Pressures with Automation & Interconnected Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

How Biotechs Can Succeed in an Increasingly Competitive Market, Upcoming Webinar Hosted by Xtalks


The featured speakers will discuss strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive environment.

The game has changed in biotech. Continued macroeconomic uncertainty has far reaching implications for the biopharma ecosystem. Access to capital remains low across the industry, and a successful deal with large pharma has become less likely for many. Companies who earlier would have been sellers, may now be progressing development through registrational studies — or all the way through to market. Stated another way, biotechs can no longer operate toward the single goal of being acquired by, or of licensing their assets to, large pharma — accordingly, players may need to develop products further than in the past, and therefore strategic pathway optionality needs to be weaved into and maintained throughout product and corporate development. With these new challenges come multifold new opportunities for value creation.

Syneos Health® and Treehill Partners are at the center of this landscape, devising concerted product, corporate and business development strategies with customers to navigate the evolving market.

In this webinar, the featured speakers will discuss strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive environment.

The speakers also look to address some pressing questions such as: How far to go as a biotech (and in what circumstances); Value focused clinical development; Strategic capital allocation; And how patients may benefit in the long run from the evolution and increasing sophistication of the biotech ecosystem.

Register now to learn about new opportunities for biotechs for value creation.

Join Lee Taurman, Global Head of Syneos One, Syneos Health; Keith Ruark, SVP Strategic Business Development, Syneos Health; and Ali Pashazadeh, Founder, Treehill Partners, for the live webinar on Thursday, May 11, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit New Opportunities for Value Creation: How Biotechs Can Succeed in an Increasingly Competitive Market.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Groschan & Associates Proudly Joins Confluent Health Family


News Image

“We are proud to partner with Groschan & Associates and have known about their clinical approach of using posture, exercise, manual therapy techniques and the most advanced technology available to get their patients back on their feet for years.” – Larry Benz, Confluent Health’s President and CEO

Confluent Health has announced its newest partnership with Groschan & Associates, a private and therapist-owned physical therapy practice with one clinic location in Lutherville, Maryland.

“Since the establishment of our practice in 2003, we have continuously evolved and devised new techniques to assist people in resolving their musculoskeletal problems,” said Jim Groschan, PT, Owner of Groschan & Associates. “Our unwavering emphasis on posture fundamentals and movement strategies is backed up by our customized treatments and exercise approach. And most of all, at the heart of our approach lies the belief in empowering people with the necessary tools to improve their own health.”

“Joining the Confluent Health family will allow our practice and staff to continue this growth while keeping our Lutherville community at the top of our mind.”

This partnership allows for Groschan & Associates to maintain its existing brand while gaining access to Confluent Health’s shared management services. These services include efficient branding, marketing, and finance tools as well as continuing education programs and staff development opportunities such as Evidence In Motion, a nationally recognized physical therapy program.

“We are proud to partner with Groschan & Associates and have known about their clinical approach of using posture, exercise, manual therapy techniques, and the most advanced technology available to get their patients back on their feet for years,” says Confluent Health’s President and CEO Larry Benz, PT, DPT, OCS, MBA, MAPP, FAPTA. “Jim and their entire team make up a pre-eminent practice in the Northeast and are going to add significant value as we grow together. Our partnership has endless possibilities.”

“As a Physical Therapist-owned business, Groschan & Associates has mastered the integration of bringing together the best clinical talent and delivering the highest quality service and care excellence. In the years to come, accommodating the vast growth and volume of musculoskeletal and chronic pain patients requires proven, hands-on partnerships and we believe Groschan & Associates is perfectly aligned to answer the call.”

Groschan & Associates’ dedication to its patrons in combination with Confluent Health’s experience in operations and efficiency will make for a positive impact in the Lutherville area.

For more information on Groschan & Associates, please visit groschanpt.com To learn more about Confluent Health, visit http://www.GoConfluent.com.

###

About Groschan & Associates:

Groschan & Associates (G&A) is a Maryland-based, private physical therapy practice group. As a proud member of the Confluent Health family, G&A positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family.

For more information, visit groschanpt.com, or find them on Facebook at @groschan.

About Confluent Health:

Confluent Health is a family of physical and occupational therapy companies that are transforming healthcare by strengthening private practices, developing highly effective clinicians, innovating new services and technology to improve the quality of care for patients, and lowering costs via more effective treatment, workplace wellness, and injury prevention.

For more information, visit goconfluent.com or find us on Facebook at @confluentfamily

Share article on social media or email: